Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / STOM

STOM

Basics

Aliases:
This biomarker is also known as:
  • BND7,
  • erythrocyte band 7 integral membrane protein,
  • Protein 7.2b,
  • protein 7.2b,
  • erythrocyte surface protein band 7.2,
  • EPB7,
  • stomatin,
  • Stomatin,
  • EPB72,
  • erythrocyte membrane protein band 7.2 (stomatin),

View in BioMuta

Description…

STOM, or stomatin, is an integral membrane protein located in the cell membrane of red blood cells and other cell types, where it is thought to regulate ion channels and transporters. Multiple transcript variants are produced by alternative splicing.

Attributes

QA State: Curated
Type: Gene
Short Name:
HGNC Name: STOM

Datasets

There are no datasets associated with this biomarker.

Organs

The following organs have data associated with this biomarker…

Breast

Attributes

Phase: Two
QA State: Under Review

Overview

No additional breast data available.

Performance Comment

STOM was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.

Prostate

Attributes

Phase: One
QA State: Under Review

Overview

Performance Comment

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 Steering Committee Meeting

The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.

Announcement 02/12/2015

Please register for the 29th EDRN Steering Committee Meeting in Atlanta, GA from March 31-April 2, 2015. The registration page has information about booking hotel rooms and a draft agenda of the meeting.

Announcement